Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective
- DOI
- 10.1007/s12325-023-02574-2
- Published
- 2023-06-21
- Container
- Advances in Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-023-02574-2,
title = {Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective},
author = {Gérard de Pouvourville and Patrick Rossignol and Meriem Boussahoua and Julie Chevalier and Peter D. Gabb and Roch Poulnais and Dorian Verboux and Naveen Rao and Elisabeth Sörstadius and Juan Jose Garcia Sanchez},
year = {2023},
journal = {Advances in Therapy},
doi = {10.1007/s12325-023-02574-2},
url = {https://doi.org/10.1007/s12325-023-02574-2}
}RIS
TY - JOUR TI - Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective AU - Gérard de Pouvourville AU - Patrick Rossignol AU - Meriem Boussahoua AU - Julie Chevalier AU - Peter D. Gabb AU - Roch Poulnais AU - Dorian Verboux AU - Naveen Rao AU - Elisabeth Sörstadius AU - Juan Jose Garcia Sanchez PY - 2023 JO - Advances in Therapy DO - 10.1007/s12325-023-02574-2 UR - https://doi.org/10.1007/s12325-023-02574-2 ER -
APA
Pouvourville, G. D., Rossignol, P., Boussahoua, M., Chevalier, J., Gabb, P. D., Poulnais, R., Verboux, D., Rao, N., Sörstadius, E., & Sanchez, J. J. G. (2023). Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective. Advances in Therapy. https://doi.org/10.1007/s12325-023-02574-2
Source records
- crossref · retrieved 2026-09-26T03:21:59.786Z